Here is a puzzle that haunts development economics: we spend billions on programs for young children in low-income countries, but most evaluations measure outcomes only a few years later. A deworming program shows kids attend school more often. A nutrition supplement improves height-for-age scores. The reports get filed, the donors feel satisfied, and everyone moves on.

But what actually happens to those children when they grow up? Do the gains persist, compound, or fade? For decades, we simply didn't know. The studies ended too soon, the budgets ran out, and the children disappeared into adulthood without anyone checking back in.

A remarkable wave of recent research has changed this. Economists and public health researchers have tracked down participants from interventions conducted twenty, thirty, even forty years ago. What they've found challenges comfortable assumptions about both the permanence and the limits of early investment — and forces a serious rethinking of how development portfolios should be structured.

Following children into adulthood sounds straightforward. In practice, it's one of the hardest things in empirical research. People migrate, change names, die, or simply become untraceable in settings without reliable administrative data. The methodological challenge alone explains why long-run follow-ups are so rare.

Yet several landmark studies have managed it. The Kenya deworming study, originally conducted by Michael Kremer and Edward Miguel starting in 1998, tracked participants more than twenty years later. The Jamaica early childhood stimulation trial, which began in the 1980s with stunted toddlers in Kingston, followed subjects into their thirties. Guatemala's INCAP nutrition supplementation study, launched in 1969, has generated data spanning over four decades.

What makes these studies credible is their original design. Each involved some form of randomization or quasi-experimental variation — meaning the children who received the intervention and those who didn't were comparable at baseline. This matters enormously. Without it, you can't distinguish the effect of the program from the effect of being the kind of family that seeks out programs.

The attrition problem — losing track of participants over time — remains a real threat to validity. Researchers have developed sophisticated methods to address this, including tracking migrants across borders and using administrative records for earnings data. But every long-run study requires scrutiny on this point. The strength of the evidence depends entirely on whether the people you find decades later are representative of the people you started with.

Takeaway

The value of a development evaluation is limited by its time horizon. Short-run results can mislead in both directions — effects that look strong may fade, and effects that look modest may compound over a lifetime.

The headline findings from these long-run follow-ups are striking. In the Kenya deworming study, men who were treated as children earned roughly 13 percent more as adults, worked more hours, and were more likely to hold manufacturing jobs rather than agricultural labor. The cost of the original intervention was less than a dollar per child per year. The implied rate of return is extraordinary by any investment standard.

The Jamaica stimulation trial tells a similar story through a different mechanism. Stunted toddlers who received two years of weekly home visits — featuring play-based cognitive and emotional stimulation — earned 25 percent more as adults than the control group. Their earnings had converged with those of a non-stunted comparison group. A psychosocial intervention essentially erased the economic penalty of early childhood malnutrition.

In Guatemala, children who received a protein-rich nutritional supplement before age three earned 46 percent more as adults than those who received a lower-calorie placebo. The effects were concentrated among those who received the supplement during the first 1,000 days of life — reinforcing a biological window that nutrition science had long suspected but rarely demonstrated with economic data.

These aren't isolated findings. A growing body of evidence from programs in Indonesia, Colombia, the Philippines, and elsewhere points in the same direction. Early childhood interventions — whether targeting nutrition, health, or cognitive stimulation — generate returns that not only persist but often grow larger over time, as initial biological and cognitive advantages compound through education, labor markets, and health trajectories.

Takeaway

The most cost-effective investments in development may be those whose full returns don't show up for two decades. Judging interventions only by short-run metrics systematically undervalues early childhood programs.

The evidence converges on a difficult truth for development practice: timing matters as much as content. The Guatemala study showed that the same nutritional supplement delivered after age three produced no detectable long-run earnings effects. The biological window for certain interventions appears to be narrow and, once closed, largely irreversible.

This has uncomfortable implications for how development portfolios are typically structured. Most aid budgets are not heavily weighted toward early childhood. Infrastructure, governance reform, secondary education, and economic growth programs absorb the majority of resources. These are important — but the long-run evidence suggests that failing to invest adequately in the first few years of life imposes costs that later interventions struggle to reverse.

It also raises equity concerns. Children born into poverty during a period when their country lacked effective early childhood programs may carry a permanent disadvantage — not because of anything intrinsic to them, but because a critical biological and developmental window passed without adequate support. The intergenerational implications are significant: mothers who were malnourished as children are more likely to have low-birthweight babies, perpetuating the cycle.

None of this means later interventions are worthless. Adolescent skills training, adult education, and labor market programs all show positive effects in rigorous evaluations. But the long-run childhood evidence suggests these programs are often compensating for deficits that earlier investment could have prevented. The question for policymakers is not whether early childhood programs work — the evidence is now quite clear. The question is whether funding allocations reflect that evidence.

Takeaway

Development is not just about what you do but when you do it. A dollar spent in a child's first thousand days may accomplish what ten dollars cannot achieve later — not because later programs fail, but because biology sets deadlines that policy cannot extend.

The long-run evidence on childhood interventions delivers a message that is both hopeful and sobering. Hopeful because relatively inexpensive programs — deworming tablets, nutritional supplements, home visits — can reshape entire life trajectories. The returns are real, large, and durable.

Sobering because every year of delay represents children passing through critical windows without support. The costs of inaction don't appear in any current budget line — they materialize decades later as forgone earnings, poorer health, and diminished human potential.

For development practice, the implication is clear: portfolio allocation should follow the evidence on timing, not just the evidence on impact. We know what works. The remaining challenge is whether institutions can prioritize investments whose political returns arrive long after the next funding cycle.